Advertisement

Cytotechnology

, Volume 66, Issue 1, pp 87–94 | Cite as

Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms

  • Husniye Tansel Yalcın
  • Mehmet Ozgün Ozen
  • Bayram Gocmen
  • Ayse NalbantsoyEmail author
Original Research

Abstract

Cytotoxic and antimicrobial effects of Montivipera xanthina venom against LNCaP, MCF-7, HT-29, Saos-2, Hep3B, Vero cells and antimicrobial activity against selected bacterial and fungal species: Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, E. coli O157H7, Enterococcus faecalis 29212, Enterococcus faecium DSM 13590, Staphylococcus epidermidis ATCC 12228, S. typhimirium CCM 5445, Proteus vulgaris ATCC 6957 and Candida albicans ATCC 10239 were studied for evaluating the potential medical benefit of this snake venom. Cytotoxicity of venom was determined using MTT assay. Snake venom cytotoxicity was expressed as the venom dose that killed 50 % of the cells (IC50). The antimicrobial activity of venom was studied by minimal inhibitory concentration (MIC) and disc diffusion assay. MIC was determined using broth dilution method. The estimated IC50 values of venom varied from 3.8 to 12.7 or from 1.9 to 7.2 μg/ml after treatment with crude venom for 24 or 48 h for LNCaP, MCF-7, HT-29 and Saos-2 cells. There was no observable cytotoxic effect on Hep3B and Vero cells. Venom exhibited the most potent activity against C. albicans (MIC, 7.8 μg/ml and minimal fungicidal concentration, 62.5 μg/ml) and S. aureus (MIC, 31.25 μg/ml). This study is the first report showing the potential of M. xanthina venom as an alternative therapeutic approach due to its cytotoxic and antimicrobial effects.

Keywords

Snake venom Cytotoxicity Antimicrobial activity Viper Montivipera xanthina 

References

  1. Ahmadi AJ, Fathi B, Jamshidi A, Zolfagharian H, Mirakabbadi AZ (2010) Investigation of the antibacterial effect of venom of the Iranian Snake Echis carinatus. Iran J Vet Sci Technol 2:93–100Google Scholar
  2. Arikan H, Göçmen B, Mermer A, Bahar H (2005) An electrophoretic comparison of the venoms of a colubrid and various viperid snakes from Turkey and Cyprus, with some taxonomic and phylogenetic implications. Zootaxa 1038:1–10Google Scholar
  3. Bastos MLA, Lima MRF, Conserva LM, Andrade VS, Rocha EMM, Lemos RPL (2009) Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents. Ann Clin Microbiol Antimicrob 8:1–6CrossRefGoogle Scholar
  4. Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496Google Scholar
  5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefGoogle Scholar
  6. Braganca BM, Hospattankar AV (1978) Potentiating Action of Cobra venom cytotoxin on the antitumour effects of alkylating agents (Melphalan). Eur J Cancer 14:707–712CrossRefGoogle Scholar
  7. Bustillo L, Leiva LC, Merino L, Acosta O, Joffé EBdK, Gorodner OJ (2008) Antimicrobial activity of Bothrops alternatus venom from the Northeast of Argentine. Rev Latinoam Microbiol 50:79–82Google Scholar
  8. Chellapandi P, Jebakumar SRD (2008) Purification and antibacterial activity of Indian Cobra and Viper Venoms. eJBio 4:11–16Google Scholar
  9. Davis HL, Ramirez G, Ellerby RA, Ansfield FJ (1974) Five-drug therapy in advanced breast cancer. Factors Influencing Toxicity and Response. Cancer 34:239–245CrossRefGoogle Scholar
  10. Francis S, Markland A (2001) Novel Snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 31:183–191Google Scholar
  11. Göçmen B, Arıkan H, Mermer A, Langerwerf B, Bahar H (2006) Morphological, hemipenial and venom electrophoresis comparisons of Levantine Viper, Macrovipera lebetina (Linnaeus, 1758) from Cyprus and Southern Anatolia. Turk J Zool 30:225–234Google Scholar
  12. Jamunaa A, Vejayan J, Halijah I, Sharifah SH, Ambu S (2012) Cytotoxicity of Southeast Asian snake venoms. J Venom Anim Toxins incl Trop Dis 18:150–156CrossRefGoogle Scholar
  13. Kaufmann SH, Vaux DL (2003) Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22:7414–7430CrossRefGoogle Scholar
  14. Koh DC, Armugam A, Jeyaseelan K (2006) Snake venom components and their applications in biomedicine. Cell Mol Life Sci 63:3030–3041CrossRefGoogle Scholar
  15. Macht DI (1940) New developments in pharmacology and therapeutics of cobra venom. Trans Am Ther Soc 40:62Google Scholar
  16. Mishra NN, Prasad T, Sharma N, Paysi A, Prasad R, Gupta DK, Singh R (2007) Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung 54:201–235CrossRefGoogle Scholar
  17. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefGoogle Scholar
  18. Nair DG, Fry BG, Alewood P, Prakash P, Kumar PP, Kini RM (2007) Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem. J 402:93–104CrossRefGoogle Scholar
  19. Nalbantsoy A, Karabay-Yavasoglu NU, Sayım F, Deliloglu-Gurhan I, Gocmen B, Arıkan H, Yildiz MZ (2012) Determination of in vivo toxicity and in vitro cytotoxicity of venom from the Cypriot blunt-nosed viper Macrovipera lebetina lebetina and antivenom production. J Venom Anim Toxins incl Trop Dis 18:208–216CrossRefGoogle Scholar
  20. NCCLS (2009) Performance standards for antimicrobial susceptibility testing, nineteenth informational supplement. Approved Standard M100-S19 National Committee for Clinical Standards. Wayne PA JanuaryGoogle Scholar
  21. Pal SK, Gomes A, Dasgupta SC, Gomes A (2002) Snake venom as therapeutic agents: from toxin to drug development. Indian J Exp Biol 40:1353–1358Google Scholar
  22. Samel M, Trummal K, Siigur E, Siigur J (2012) Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation. Toxicon 60:648–655CrossRefGoogle Scholar
  23. Samy RP, Pachiappan A, Gopalakrishnakone P, Thwin MM, Hian YE, Chow VTK, Bow H, Weng JT (2006) In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei. BMC Infect Dis 6:1–16CrossRefGoogle Scholar
  24. Samy RP, Gopalakrishnakone P, Thwin MM, Chow TKV, Bow H, Yap EH, Thong TWJ (2007) Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J Appl Microbiol 102:650–659CrossRefGoogle Scholar
  25. San TM, Vejayan J, Shanmugan K, Ibrahim H (2010) Screening antimicrobial activity of venoms from snakes commonly found in Malasia. J Appl Sci 10:2328–2332CrossRefGoogle Scholar
  26. Shebl RI, Mohamed AF, Ali AE, Amin MA (2012) Cerastes cerastes and Vipera lebetina Snake Venoms apoptotic—stimulating activity to human breast cancer cells and related gene modulation. J Cancer Sci Ther 4:317–323Google Scholar
  27. Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, Yang D, Markland FS Jr (2004) Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther 3:499–511Google Scholar
  28. Tare TG, Sutar NK, Renapurkar DM (1986) A study of snake venom yield by different methods of venom extraction. Amphib Reptile 7:187–191CrossRefGoogle Scholar
  29. Wilson TR, Johnston PG, Longley DB (2009) Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets 9:307–319CrossRefGoogle Scholar
  30. Zare MA, Mahdavi S, Koohi MK, Taghavian M (2008) Cytotoxic effect of ICD-85 (venom- derived peptides) on MDA-MB-231 cell line. J Venom Anim Toxins incl Trop Dis 14:180–186Google Scholar
  31. Zhou Q, Nakada MT, Arnold C, Markland FS (1999) Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inbibits angiogenesis. Angiogenesis 3:259–269CrossRefGoogle Scholar
  32. Zhou Q, Wulfkuhle J, Ouatas T, Fukushima P, Stetler-Stevenson M, Miller FR, Steeg PS (2000) Contortrostatin, a dimeric disintegrin from agkistrodo contortrix, inbibit s breast cancer progression. Breast Cancer Res Treat 61:249–260Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Husniye Tansel Yalcın
    • 1
  • Mehmet Ozgün Ozen
    • 2
  • Bayram Gocmen
    • 3
  • Ayse Nalbantsoy
    • 2
    Email author
  1. 1.Department of Biology, Basic and Industrial Microbiology Section, Faculty of ScienceEge UniversityBornovaTurkey
  2. 2.Department of Bioengineering, Faculty of EngineeringEge UniversityBornovaTurkey
  3. 3.Department of Biology, Zoology Section, Faculty of ScienceEge UniversityBornovaTurkey

Personalised recommendations